Journal
CANCER CELL
Volume 39, Issue 12, Pages 1562-1564Publisher
CELL PRESS
DOI: 10.1016/j.ccell.2021.11.001
Keywords
-
Categories
Ask authors/readers for more resources
Zhang et al. conducted extensive single-cell immune compartment analyses of pre- and post-therapy triple-negative breast cancer and revealed potential mechanisms of T cell activation and patterns of immune evolution, which may inform future biomarkers of response and clinical benefit.
Immune checkpoint blockade plus chemotherapy is emerging as a standard treatment for some patients with triple-negative breast cancer (TNBC). In this issue of Cancer Cell, Zhang et al. employ extensive single-cell immune compartment analyses of preand post-therapy TNBC, and they reveal potential mechanisms of T cell activation and patterns of immune evolution that may inform future biomarkers of response and clinical benefit.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available